Mauna Kea, Cook Medical Partner on Urology Endomicroscope Commercialization
Cook Medical will commercialize a private-label version of Mauna Kea Technologies Inc.'s confocal laser endomicroscopy platform Cellvizio for urological applications.
The launch in North America, Western Europe and China is planned for the first half of 2016.
Urological applications of confocal laser endomicroscopy with Cellvizio may include detection and surveillance of bladder cancer and the characterization of upper urinary tract urothelial cancer, the companies said.
Headquartered in Bloomington, Ind., Cook Medical, a division of the Cook Group Inc., produces medical devices and supplies, with specific expertise in urology applications.
Cellvizio is the flagship product of Mauna Kea Technologies SA, a global medical device company.
For more information, visit
www.maunakeatech.com.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024